Literature DB >> 9781600

A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagus.

C F Slabber1, J S Nel, L Schoeman, W Burger, G Falkson, C I Falkson.   

Abstract

Squamous cell cancer of the esophagus is the most common cancer among black South African males, and 60% of patients present with localized inoperable disease. Combined chemoradiotherapy has been reported to be superior to radiotherapy alone for localized inoperable esophageal cancer in North American patients. A study was carried out to determine if this was also applicable to South African patients, who present with more advanced disease. From September 1991 through June 1995, 70 patients with locally advanced (T3N0-1M0) squamous cancer of the esophagus were prospectively randomized to receive radiotherapy alone or radiotherapy combined with cisplatin and 5-fluorouracil. There was no statistically significant survival difference between the two groups. The median survival was 144 days in the group receiving radiotherapy alone, and 170 days in the group receiving radiotherapy combined with chemotherapy (p = 0.42). The degree of weight loss before initiation of therapy had a significant effect on survival regardless of the treatment arm. Radiotherapy in combination with chemotherapy, as administered in this study for South African patients with locally advanced, inoperable squamous cancer of the esophagus, is no better than radiotherapy alone.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9781600     DOI: 10.1097/00000421-199810000-00008

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  13 in total

1.  [Palliative options for esophageal carcinoma].

Authors:  F Hagenmüller
Journal:  Chirurg       Date:  2005-11       Impact factor: 0.955

2.  Chemoradiotherapy for esophageal cancer.

Authors:  Geoffrey Neuner; Ashish Patel; Mohan Suntharalingam
Journal:  Gastrointest Cancer Res       Date:  2009-03

3.  Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer.

Authors:  Maria Wolf; Franz Zehentmayr; Maximilian Niyazi; Ute Ganswindt; Wolfgang Haimerl; Michael Schmidt; Dieter Hölzel; Claus Belka
Journal:  Strahlenther Onkol       Date:  2010-06-24       Impact factor: 3.621

4.  Incurable esophageal cancer: patterns of tumor spread and therapeutic consequences.

Authors:  Ines Gockel; Werner Kneist; Theodor Junginger
Journal:  World J Surg       Date:  2006-02       Impact factor: 3.352

Review 5.  Is Clinical Research in Oesophageal Cancer in South Africa in Crisis? A Systematic Review.

Authors:  E Loots; B Sartorius; T E Madiba; C J J Mulder; D L Clarke
Journal:  World J Surg       Date:  2017-03       Impact factor: 3.352

Review 6.  [Palliative treatment options for esophageal and gastric cancer].

Authors:  A Eickhoff; R Jakobs; J F Riemann
Journal:  Internist (Berl)       Date:  2004-07       Impact factor: 0.743

7.  Radiotherapy versus stenting in treating malignant dysphagia.

Authors:  Hany Eldeeb; Hend Ahmed El-Hadaad
Journal:  J Gastrointest Oncol       Date:  2012-12

8.  Single centre outcomes from definitive chemo-radiotherapy and single modality radiotherapy for locally advanced oesophageal cancer.

Authors:  Ben Alexander Fulton; Joanna Gray; Alexander McDonald; David McIntosh; Vivienne MacLaren; Aisling Hennessy; Derek Grose
Journal:  J Gastrointest Oncol       Date:  2016-04

9.  Survival after chemotherapy and/or radiotherapy versus self-expanding metal stent insertion in the setting of inoperable esophageal cancer: a case-control study.

Authors:  George Sgourakis; Ines Gockel; Constantine Karaliotas; Markus Moehler; Carl Christoph Schimanski; Heinz Schmidberger; Theodor Junginger
Journal:  BMC Cancer       Date:  2012-02-15       Impact factor: 4.430

10.  Outcome for esophageal cancer following treatment with chemotherapy and radiotherapy but not esophagectomy: Nonsurgical treatment of esophageal cancer.

Authors:  Urs Zingg; Dennis Divalentino; Alexander McQuinn; Ahmad Mardzuki; Sarah K Thompson; Christos S Karapetis; David I Watson
Journal:  Clin Exp Gastroenterol       Date:  2009-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.